Oxygen & RespiratoryJuly 11, 2026·5 min read
By the CIRRUS Editorial Team — how we write and source this
Interstitial lung disease and oxygen needs: how pulmonary fibrosis changes the prescription
ILD doesn't progress like COPD, and neither does its oxygen prescription. Why exertional desaturation shows up before resting hypoxemia does, and what that means for the machine you actually need.
Interstitial lung disease — a category that includes idiopathic pulmonary fibrosis and dozens of related scarring conditions — behaves differently from COPD in a way that matters directly for oxygen prescribing: desaturation on exertion tends to show up well before resting oxygen levels drop. A patient can have a normal pulse ox reading sitting still and drop into the low 80s walking to the mailbox. That pattern is why a one-time resting SpO2 check misses the actual clinical picture, and why pulmonologists managing ILD lean heavily on walking oximetry and formal exertional desaturation testing rather than a single static reading.
The practical consequence is a prescription that's frequently exertion-specific rather than continuous — a flow rate for walking and activity that's meaningfully higher than what the same patient needs at rest, sometimes with no resting oxygen requirement at all in earlier disease stages. This is one of the more common places where a pulse-dose portable's marketed 'equivalent to X LPM continuous' framing runs into a real limitation: pulse delivery is timed to inhalation, and a patient breathing faster and shallower during exertion — exactly the ILD pattern — can get less effective oxygen per breath than the same setting delivers to someone breathing at rest.
As ILD progresses, resting hypoxemia usually does develop, and the prescription shifts toward continuous-flow needs that scale with disease stage rather than staying fixed. This is part of why we see IPF and other ILD patients revisit their equipment more often than a typical COPD patient on a stable long-term prescription — the disease's progression curve is generally steeper, and the equipment conversation benefits from checking in with pulmonology on a shorter interval rather than assuming this year's settings hold for next year.
None of this changes the ownership math for anyone paying out of pocket: a continuous-flow-capable stationary unit paired with a pulse-dose portable for mobility covers both ends of the ILD prescription curve, and buying outright means adjusting flow settings as the prescription changes doesn't require renegotiating a rental agreement.
This article is general health information, not medical advice, and doesn’t replace evaluation by your own physician. Talk to a doctor about anything specific to your own diagnosis or treatment.
